[1] American Society of Hospita1 Pharmacists.ASHP statement on the use of medications for unlabeled uses[J].Am J Hosp Pharm,1992,49(8):2006.
[2] Stafford RS.Regulating off-label drug use-rethinking the role of the FDA[J].N Engl J Med,2008,358(14):1427.
[3] 张伶俐, 李幼平, 黄 亮等.四川大学华西第二医院2010年儿科门诊患儿超说明书用药情况调查[J].中国循证医学杂志2012, 12(3): 267-273.
[4] 陈冬裕.对现行中成药说明书的调查和思考[J].中国药房,2009, 20(9): 718-720.
[5] 苏洽玉,陈海坤.558份化学药品说明书的调查分析[J].中国药房,2008,04(35): 316-318.
[6] 杨玉龙.正确认识超说明书用药[J].首都医药,2012,10: 42-43.
[7] 宋儒亮.超说明书用药患者与医生的权益保护[J].中国处方药,2012, 12(106): 10-11.
[8] 广东省药学会.药品未注册用法专家共识[Z].粤药会[2010] 8号,2010.
[9] 张伶俐, 李幼平, 曾力楠,等.15国超说明书用药政策的循证评价[J].中国循证医学杂志,2012,12(4):426-435.
[10] Cheng AC, Robinson PM, Harvey K.Off-label use of medicines:consensus recommendations for evaluating appropriateness[J].MIA, 2007, 186(7): 379-380.
[11] Australian Government Department of Health and Ageing. Health and ageing thesaurus[EB/OL]. (2011-11-26)[2013-06-28]http://www.health.gov.au/internet/main/publishing.nsf/Content/health-thesaurus.htm.
[12] AHFS. About AHFS[EB/OL]. (2013-03-26)[2013-06-20]http://www.ahfsdruginformation.com/about_ahfs/.
[13] 刘 宇.药品说明书之外用法的法律风险提示及对策[J].协和医学杂志,2010,1(1):1.